Targeting the DNA damage response for patients with lymphoma: Preclinical and clinical evidences-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeting the DNA damage response for patients with lymphoma: Preclinical and clinical evidences

Published:2020-11 Issue: Volume:90 Page:102090
ISSN:0305-7372
Container-title:Cancer Treatment Reviews
language:en
Short-container-title:Cancer Treatment Reviews

Author:

Carrassa Laura,Colombo Ilaria,Damia Giovanna,Bertoni Francesco

Funder

Associazione Italiana per la Ricerca sul Cancro

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Reference204 articles.

1. The DNA damage response: making it safe to play with knives;Ciccia;Mol Cell,2010

2. The DNA-damage response in human biology and disease;Jackson;Nature,2009

3. DNA damage response inhibitors: Mechanisms and potential applications in cancer therapy;Carrassa;Cancer Treat Rev,2017

4. Genomic instability–an evolving hallmark of cancer;Negrini;Nat Rev Mol Cell Biol,2010

5. DNA repair pathways as targets for cancer therapy;Helleday;Nat Rev Cancer,2008

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CRISPR-Cas9 Knockout Screens Identify DNA Damage Response Pathways and BTK as Essential for Cisplatin Response in Diffuse Large B-Cell Lymphoma;Cancers;2024-07-02

2. The ATR inhibitor elimusertib exhibits anti‐lymphoma activity and synergizes with the PI3K inhibitor copanlisib;British Journal of Haematology;2023-11-27

3. The Complex Network of ADP-Ribosylation and DNA Repair: Emerging Insights and Implications for Cancer Therapy;International Journal of Molecular Sciences;2023-10-09

4. MYD88 Wild Type in IgM Monoclonal Gammopathies: From Molecular Mechanisms to Clinical Challenges;Hemato;2023-09-13

5. Targeting CD19-positive lymphomas with the antibody-drug conjugate (ADC) loncastuximab tesirine: preclinical evidence as single agent and as combinatorial approach;2023-08-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3